Global Molecular Diagnostics Market, 2019 - Research and Markets
DUBLIN, June 16, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing, Market Size, Strategies and Forecasts 2016-2019 - Global Version" report to their offering.
"Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 Medicare Fee Payment Schedules to help understand test pricing in detail. See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions.
Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges.
Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in genomics knowledge. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- personalized medicine
- pharmacogenomics
- pathogen evolution
- next generation sequencing
- emergence of new economies with large markets
- greater understanding of the role of genetic material in Disease and Health
Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report data is designed to be used! The unit volumes of tests performed is presented. Use our pricing scenarios or use your own. Project your market share and your price to reliably generate revenue forecasts or understand your own current market share position. Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Infectious Disease, Genetic Testing, Oncology Testing.
Key Topics Covered:
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Molecular Diagnostics Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
Companies Mentioned
- 14M Genomics
- 23andMe
- Agendia
- Agilent/Dako
- All About Truth DNA Services
- Allenex
- AltheaDx
- Amarantus
- Ariosa Diagnostics
- CareDx
- Cepheid
- Firefly BioWorks
- GenomeDx Biosciences
- Genomic Health
- Genomic Vision
- Glyconics
- Good Start Genetics
- Google
- Great Basin Scientific
- Grifols
- Hologic
- HTG Molecular Diagnostics
- Human Longevity
- Illumina
- NanoString
- NEO New Oncology
- Newtopia Garners
- Precipio
- Premaitha
- Protagen
- Roche Molecular Diagnostics
- Rosetta
- Sequenom
- Sequenta
- Sera
For more information visit http://www.researchandmarkets.com/research/f2m9x8/molecular
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article